Trademark: 79279558
Word
XEMVEQ
Status
Registered
Status Code
700
Status Date
Tuesday, July 7, 2020
Serial Number
79279558
Registration Number
6093308
Registration Date
Tuesday, July 7, 2020
Mark Type
4000
Filing Date
Monday, January 13, 2020
Published for Opposition
Tuesday, April 21, 2020

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events
Jul 30, 2023
Change Of Name/Address Rec'd From Ib
Oct 10, 2020
Notification Processed By Ib
Sep 18, 2020
Final Disposition Notice Sent To Ib
Sep 17, 2020
Final Disposition Processed
Aug 6, 2020
Grant Of Protection Created, To Be Sent To Ib
Jul 7, 2020
Registered-Principal Register
Apr 21, 2020
Published For Opposition
Apr 1, 2020
Notice Of Publication
Mar 18, 2020
Approved For Pub - Principal Register
Mar 15, 2020
Assigned To Examiner
Mar 6, 2020
Application Filing Receipt Mailed
Mar 2, 2020
New Application Office Supplied Data Entered
Feb 28, 2020
Limitation From Original Application Entered
Feb 27, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24